Newsroom

麻薩諸塞州萊辛頓--(BUSINESS WIRE)--(美國商業資訊)-- 免疫腫瘤學創新領域的領導者Agenus Inc. (Nasdaq: AGEN)今日宣布，法國國家藥品和健康產品安全局(ANSM)已核准一項更新後的國家治療方案，將botensilimab (BOT)聯合balstilimab (BAL)的組合療法納入法國同情用藥授權(AAC)架構。 此前，法國已核准BOT+BAL組合療法用於不存在活動性肝轉移的微衛星穩定型(MSS)轉移性大腸癌(mCRC)病患的AAC授權。本次更新後的方案將適用人群擴大至特定卵巢癌和軟組織肉瘤病患——這些病患在標準治療方案用盡後，仍存在未被滿足的重大醫療需求。 修訂後的方案進一步擴大了病患准入標準，讓更多晚期實質腫瘤病患能透過同情使用途徑，儘早獲得可全額報銷的BOT+BAL組合療法治療，並強化參與醫院的監測和治療流程。 BOT+BAL是一種無需化療和放療的免疫治療組合療法，目前正處於臨床研究階段，且可透過ANSM授權的同情使用通路取得。在迄今展開的研究中，該療法在既往接受過大量治療的病患群體中觀察到了抗腫瘤活性，其中包括那些對標準免疫治療方案應...

马萨诸塞州列克星敦--(BUSINESS WIRE)--(美国商业资讯)-- 免疫肿瘤学创新领域的领导者Agenus Inc. (Nasdaq: AGEN)今日宣布，法国国家药品和健康产品安全局(ANSM)已批准一项更新后的国家治疗方案，将botensilimab (BOT)联合balstilimab (BAL)的组合疗法纳入法国同情用药授权(AAC)框架。 此前，法国已批准BOT+BAL组合疗法用于不存在活动性肝转移的微卫星稳定型(MSS)转移性结直肠癌(mCRC)患者的AAC授权。本次更新后的方案将适用人群拓展至特定卵巢癌和软组织肉瘤患者——这些患者在标准治疗方案用尽后，仍存在大量未被满足的医疗需求。 修订后的方案进一步拓宽了患者准入标准，让更多晚期实体瘤患者能通过同情使用途径，尽早获得可全额报销的BOT+BAL组合疗法治疗，并加强参与医院的监测和治疗流程。 BOT+BAL是一种无需化疗和放疗的免疫治疗组合疗法，目前正处于临床研究阶段，且可通过ANSM授权的同情使用渠道获取。在迄今开展的研究中，该疗法在既往接受过大量治疗的患者群体中观察到了抗肿瘤活性，其中包括那些对标准免疫治疗方案...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 12.01.2026 FVD. IE00BKVKW020 250,002.00 USD 7,115,575.99 28.462  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 12.01.2026 FCSG IE00BKPSPT20 1,425,002.00 USD 62,444,557.33 43.821  ...

HOUSTON--(BUSINESS WIRE)--A lawsuit filed in Harris County accuses an Aramark employee at NRG Stadium of sexually assaulting an 8-year-old boy in a restroom during a Houston Texans football game on Dec. 14. The employee was arrested following the incident and is awaiting trial. Aramark Sports and Entertainment Services of Texas LLC and ASM Global Parent Inc., which manages the Harris County-owned NRG Park, are defendants in the case along with Ushay Nixon, an Aramark employee, whom police are c...

DUBLIN--(BUSINESS WIRE)--The "Naval Weapon Systems - Market and Technology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This study explores how conventional naval weapon systems are being reshaped into modern, multi-domain combat solutions. It examines the technological advances being adopted by leading navies and how these transformations are influencing market dynamics and future demand, especially as global modernisation programmes take centre stage in procur...

DUBLIN--(BUSINESS WIRE)--The "Precision Guided Munitions - Market and Technology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. A detailed insight of the Precision Guided Munition market in the 2025-2033 period, including highlights of the demand drivers, trends, and challenges. It also provides a snapshot of the spending with respect to regions as well as segments and sheds light on the emergence of new technologies. Precision guided munitions encompass a broad s...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: First Trust Advisors L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be name...

HOUSTON--(BUSINESS WIRE)--Lightning Step and Sunwave today announced that both organizations have successfully achieved SOC 2 Type II attestation across all five Trust Services Criteria - Security, Availability, Confidentiality, Processing Integrity, and Privacy. This is a significant milestone as a full - scope attestation that reinforces their commitment to the highest standards of data security, privacy, and operational integrity within the healthcare technology sector. This independent atte...

DUBLIN--(BUSINESS WIRE)--The "Missiles - Market and Technology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. This study examines, analyses, and predicts the evolution of missile technologies, markets, and outlays (expenditures) over the next 8 years: 2025-2033. It also examines the major missile system markets geographically, focusing on the top 95% of global markets, in the United States, Europe, and Asia. In this study we analyse the market size of the global m...